Franco Poletti's most recent trade in LivaNova PLC was a trade of 13,986 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 13,986 | 13,986 | - | - | Stock Appreciation Rights | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 6,388 | 6,388 | - | - | Restricted Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 6,388 | 6,388 | - | - | Performance Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 3,194 | 3,194 | - | - | Performance Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2025 | 3,194 | 3,194 | - | - | Performance Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 1,257 | 8,475 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 559 | 1,675 | - | - | Restricted Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.13 per share. | 30 Mar 2025 | 542 | 7,933 (0%) | 0% | 39.1 | 21,208 | Ordinary Shares |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 325 | 650 | - | - | Restricted Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 201 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2025 | 172 | 171 | - | - | Restricted Stock Units | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Dec 2024 | 967 | 7,634 (0%) | 0% | 0 | Ordinary Shares | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Dec 2024 | 967 | 967 | - | - | Restricted Stock Units | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Dec 2024 | 416 | 7,218 (0%) | 0% | 51.5 | 21,424 | Ordinary Shares | |
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Sep 2024 | 5,885 | 5,885 | - | - | Stock Appreciation Rights | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Sep 2024 | 2,575 | 2,575 | - | - | Restricted Stock Units | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Sep 2024 | 2,575 | 2,575 | - | - | Performance Stock Units | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Sep 2024 | 1,287 | 1,287 | - | - | Performance Stock Units | ||
| LivaNova PLC | Franco Poletti | President, Cardiopulmonary | 15 Sep 2024 | 1,287 | 1,287 | - | - | Performance Stock Units |